Quercis Pharma and The Galien Foundation to Spotlight Sickle Cell Disease at the 2025 Patient SummitNEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Quercis Pharma is proud to sponsor Panel 6 — “The Forgotten Patients: A Focus on Sickle Cell Disease” at The Galien Foundation’s 2025 Patient Summit, taking place on Thursday, October 30, 2025, at the Alexandria Center for Life Sciences in New York City. The session, scheduled for 4:05–5:05 p.m. ET, will bring together globally recognized clinicians, researchers, and patient advocates to address the persistent gaps in care for individuals living with sickle cell disease (SCD).
Quercis Pharma and Thomas Lines Nominated for Prestigious Prix Galien USA “Best Startup” AwardRecognition highlights company’s antithrombotic platform and late-stage programs designed to transform care in oncology and inflammation driven diseases
